Fortrea Holdings (FTRE) Net Cash Flow (2022 - 2026)

Fortrea Holdings (FTRE) posted Net Cash Flow of -$25.0 million for Q1 2026, down 154.47% on a QoQ basis from $45.9 million in Q4 2025, and down 26.9% year-over-year from -$34.2 million in Q1 2025.

Fortrea Holdings (FTRE) Net Cash Flow (2022 - 2026) Analysis & Trends

Fortrea Holdings' Net Cash Flow history runs 5 years deep, the most recent figure standing at -$25.0 million for Q1 2026.

  • Quarterly Net Cash Flow fell 26.9% year-over-year to -$25.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.3 million (up 345.19% YoY) and the FY2025 annual result came in at $51.6 million, up 210.84% from the prior year.
  • Net Cash Flow was -$25.0 million for Q1 2026 at Fortrea Holdings, down from $45.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $50.1 million in Q3 2025 and bottomed at -$25.0 million in Q1 2026.
  • A 5-year average of $3.7 million and a median of -$800000.0 in 2022 frame the typical range for Net Cash Flow.
  • Peak annual rise in Net Cash Flow reached 1047.06% in 2024, while the deepest fall reached 690.32% in 2024.
  • Fortrea Holdings' Net Cash Flow stood at -$800000.0 in 2022, then surged by 312.5% to $1.7 million in 2023, then jumped by 1047.06% to $19.5 million in 2024, then jumped by 135.38% to $45.9 million in 2025, then slumped by 154.47% to -$25.0 million in 2026.
  • Business Quant data shows FTRE's Net Cash Flow at -$25.0 million in Q1 2026, $45.9 million in Q4 2025, and $50.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 10.56 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 224.46 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.34 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 457.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -152.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 57.19 Mn
10 Fortrea Holdings 1.83 Bn 1.68 Bn 123.60 Mn -25.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -25.00 Mn
Mar 31, 2026 -25.00 Mn
Dec 31, 2025 45.90 Mn
Dec 31, 2025 45.90 Mn
Sep 30, 2025 50.10 Mn
Sep 30, 2025 50.10 Mn
Jun 30, 2025 -24.70 Mn
Jun 30, 2025 -24.70 Mn
Mar 31, 2025 -19.70 Mn
Mar 31, 2025 -19.70 Mn
Dec 31, 2024 19.50 Mn
Dec 31, 2024 19.50 Mn
Sep 30, 2024 -24.50 Mn
Sep 30, 2024 -24.50 Mn
Jun 30, 2024 35.10 Mn
Jun 30, 2024 35.10 Mn
Mar 31, 2024 -13.50 Mn
Mar 31, 2024 -13.50 Mn
Dec 31, 2023 1.70 Mn
Dec 31, 2023 1.70 Mn